(2R,3R,4S)-3-(2-azidoacetamido)-4-hydroxy-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylate

ID: ALA1289862

Chembl Id: CHEMBL1289862

PubChem CID: 52948463

Max Phase: Preclinical

Molecular Formula: C11H16N4O8

Molecular Weight: 332.27

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  [N-]=[N+]=NCC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CO)OC(C(=O)O)=C[C@@H]1O

Standard InChI:  InChI=1S/C11H16N4O8/c12-15-13-2-7(19)14-8-4(17)1-6(11(21)22)23-10(8)9(20)5(18)3-16/h1,4-5,8-10,16-18,20H,2-3H2,(H,14,19)(H,21,22)/t4-,5+,8+,9+,10+/m0/s1

Standard InChI Key:  OLOYDWMIOMMPCV-NCJYIMSCSA-N

Associated Targets(Human)

NEU3 Tchem Sialidase 3 (398 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NEU4 Tchem Sialidase 4 (267 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NEU2 Tbio Sialidase 2 (382 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NEU1 Tchem Sialidase 1 (236 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 332.27Molecular Weight (Monoisotopic): 332.0968AlogP: -2.78#Rotatable Bonds: 7
Polar Surface Area: 205.31Molecular Species: ACIDHBA: 8HBD: 6
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.10CX Basic pKa: CX LogP: -3.69CX LogD: -7.26
Aromatic Rings: 0Heavy Atoms: 23QED Weighted: 0.16Np Likeness Score: 1.28

References

1. Zou Y, Albohy A, Sandbhor M, Cairo CW..  (2010)  Inhibition of human neuraminidase 3 (NEU3) by C9-triazole derivatives of 2,3-didehydro-N-acetyl-neuraminic acid.,  20  (24): [PMID:21036040] [10.1016/j.bmcl.2010.09.111]
2. Albohy A, Zhang Y, Smutova V, Pshezhetsky AV, Cairo CW..  (2013)  Identification of Selective Nanomolar Inhibitors of the Human Neuraminidase, NEU4.,  (6): [PMID:24900705] [10.1021/ml400080t]
3. Cairo CW.  (2014)  Inhibitors of the human neuraminidase enzymes,  (8): [10.1039/C4MD00089G]
4. Guo T, Héon-Roberts R, Zou C, Zheng R, Pshezhetsky AV, Cairo CW..  (2018)  Selective Inhibitors of Human Neuraminidase 1 (NEU1).,  61  (24): [PMID:30457869] [10.1021/acs.jmedchem.8b01411]
5. Bourguet E, Figurska S, Fra Czek MM..  (2022)  Human Neuraminidases: Structures and Stereoselective Inhibitors.,  65  (4.0): [PMID:35170942] [10.1021/acs.jmedchem.1c01612]

Source